clinical trial · NCT05459948
The Medacta GMK SpheriKA Post-Marketing Surveillance Study
Medacta International SA·—·recruiting·n = 281
ArthropathyKnee ReplacementGMK SpheriKA
brief summary
This is a Post-Marketing Surveillance of GMK SpheriKA knee stem prosthesis.
started
Jul 30, 2022
primary completion
May 1, 2035
completion
May 1, 2035
last updated
Sep 29, 2025
detailed description
The aim of the current study is to collect clinical and radiological data to monitor the performances of the "GMK® SpheriKA" Knee Prosthesis implanted via the kinematic alignment technique.
official title
Medacta GMK® SpheriKA and Kinematic Alignment Technique Multicenter, Post-Market Outcome Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol